drugset
drugset / Trial / NCT04092712

Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers

NCT04092712 ↗

Phase 1 Completed 6 enrolled Concert Pharmaceuticals Celerion · collab
NaSingle-groupOpen-labelBasic science

Summary

This study will assess the absorption, metabolism, excretion, mass balance, safety, and tolerability of a single oral administration of \[14C\]-CTP-543 in healthy male subjects.

Timeline

Start
2019-09-05
Primary completion
2019-09-11
Completion
2019-09-20

Drugs

EvaluationDrugModalityDoseRoute
Subject CTP-543 Unknown 2.775 mbq Oral

Indications

No indication recorded.